Yield10 Bioscience Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Yield10 Bioscience.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 27.6% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Yield10 Bioscience GAAP EPS of $0.70 beats by $1.39, revenue of $0.1M misses by $0.06M
Aug 10Is Yield10 Bioscience (NASDAQ:YTEN) In A Good Position To Invest In Growth?
Nov 12Yield10 Bioscience (NASDAQ:YTEN) Is In A Good Position To Deliver On Growth Plans
Jul 19Yield10 Bioscience, Inc.'s (NASDAQ:YTEN) CEO Will Probably Find It Hard To See A Huge Raise This Year
May 18Here's Why We're Watching Yield10 Bioscience's (NASDAQ:YTEN) Cash Burn Situation
Apr 14Yield10 Bio secures $12.7M capital raise
Feb 01Yield10 Bioscience under pressure on launching stock offering
Jan 29When Will Yield10 Bioscience, Inc. (NASDAQ:YTEN) Become Profitable?
Jan 22In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Yield10 Bioscience has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 1 | -13 | -6 | -6 | N/A |
3/31/2024 | 0 | -13 | -8 | -8 | N/A |
12/31/2023 | 0 | -14 | -10 | -10 | N/A |
9/30/2023 | 0 | -14 | -11 | -11 | N/A |
6/30/2023 | 0 | -14 | -12 | -12 | N/A |
3/31/2023 | 0 | -14 | -11 | -11 | N/A |
12/31/2022 | 0 | -14 | -12 | -11 | N/A |
9/30/2022 | 1 | -13 | -11 | -11 | N/A |
6/30/2022 | 0 | -12 | -10 | -10 | N/A |
3/31/2022 | 1 | -12 | -10 | -10 | N/A |
12/31/2021 | 1 | -11 | -9 | -9 | N/A |
9/30/2021 | 1 | -11 | -9 | -9 | N/A |
6/30/2021 | 1 | -10 | -9 | -9 | N/A |
3/31/2021 | 1 | -9 | -9 | -9 | N/A |
12/31/2020 | 1 | -10 | -9 | -9 | N/A |
9/30/2020 | 1 | -14 | -10 | -10 | N/A |
6/30/2020 | 1 | -14 | -9 | -9 | N/A |
3/31/2020 | 1 | -14 | -9 | -9 | N/A |
12/31/2019 | 1 | -13 | -9 | -9 | N/A |
9/30/2019 | 1 | -8 | -7 | -7 | N/A |
6/30/2019 | 1 | -9 | -8 | -8 | N/A |
3/31/2019 | 1 | -9 | -8 | -8 | N/A |
12/31/2018 | 1 | -9 | -9 | -9 | N/A |
9/30/2018 | 1 | -11 | -9 | -9 | N/A |
6/30/2018 | 1 | -11 | -9 | -9 | N/A |
3/31/2018 | 1 | -11 | N/A | -9 | N/A |
12/31/2017 | 1 | -11 | N/A | -8 | N/A |
9/30/2017 | 1 | -8 | N/A | -9 | N/A |
6/30/2017 | 1 | -8 | N/A | -11 | N/A |
3/31/2017 | 1 | -8 | N/A | -10 | N/A |
12/31/2016 | 1 | -9 | N/A | -14 | N/A |
9/30/2016 | 1 | -11 | N/A | -17 | N/A |
6/30/2016 | 0 | -7 | N/A | -17 | N/A |
3/31/2016 | 1 | -10 | N/A | -22 | N/A |
12/31/2015 | 1 | -12 | N/A | -22 | N/A |
9/30/2015 | 2 | -15 | N/A | -22 | N/A |
6/30/2015 | 3 | -24 | N/A | -23 | N/A |
3/31/2015 | 3 | -25 | N/A | -22 | N/A |
12/31/2014 | 3 | -27 | N/A | -25 | N/A |
9/30/2014 | 2 | -29 | N/A | -25 | N/A |
6/30/2014 | 1 | -28 | N/A | -26 | N/A |
3/31/2014 | 2 | -29 | N/A | -27 | N/A |
12/31/2013 | 4 | -29 | N/A | -27 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if YTEN.Q's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if YTEN.Q's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if YTEN.Q's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if YTEN.Q's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if YTEN.Q's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if YTEN.Q's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/27 16:26 |
End of Day Share Price | 2024/12/27 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yield10 Bioscience, Inc. is covered by 16 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Han Jang | Aegis Capital Corporation |
Jinming Liu | Ardour Capital Investments, LLC |
Benjamin Klieve | B. Riley Wealth |